The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial

New publication on The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial from the American Heart Journal

The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial

#vascularaccess #FOAMva #FOAMed #FOAMcc #FOAMus #FOAMrad #FOAMped #FOAMem

Monitoring of anticoagulant therapy in cancer patients with thrombosis and the usefulness of blood activation markers

New publication on Monitoring of anticoagulant therapy in cancer patients with thrombosis and the usefulness of blood activation markers from Transfusion and Apheresis Science

Monitoring of anticoagulant therapy in cancer patients with thrombosis and the usefulness of blood activation markers

#vascularaccess #FOAMva #FOAMed #FOAMem #FOAMcc #FOAMems